2 years on: deborah discusses her venetoclax trial and becoming mrd negative
Published 7 years ago • 1.6K plays • Length 8:26Download video MP4
Download video MP3
Similar videos
-
0:49
venice ii trial: health-related qol in patients with cll treated with venetoclax
-
2:19
cladribine ldac venetoclax alternated with azacitidine venetoclax in older patients with aml
-
1:28
venetoclax & dose-reduced chemotherapy for the treatment of older adults with b-all and t-all
-
1:46
phase ii trial in progress: astx727 ± venetoclax in newly diagnosed mds/mpn
-
1:09
taking mrd from trials to the clinic
-
0:58
dara-rvd in the treatment of hr-smm: an ongoing phase ii trial
-
1:10
a trial investigating ibervd in transplant-ineligible newly diagnosed multiple myeloma
-
4:50
esmo 2024: braf-altered colorectal and other cancers
-
7:43
living well with cll
-
3:06
mechanism of action of venetoclax (abt-199) and its side effects
-
2:09
heart transplantation in attr amyloidosis
-
0:33
the management of elderly patients with cll
-
5:07
a new horizon: melflufen for r/r multiple myeloma
-
2:41
bcl2 family changes associated with venetoclax resistance in multiple myeloma
-
1:13
venetoclax for elderly all?
-
3:05
current research in elderly, untreated aml: venetoclax combinations
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
2:55
a model including cd49d expression to predict outcomes in patients with cll treated with ibrutinib
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:25
an update on the emn19 study: dara-vcd in multiple myeloma
-
2:36
mrd-driven addition of ibrutinib to venetoclax for cll